[1]
2024. Attenuating Renal Interstitial Fibrosis by Shenqi Pill via Reducing Inflammation Response Regulated by NF-κB Pathway In Vitro and In Vivo. Iranian Journal of Kidney Diseases. 18, 2 (Apr. 2024), 87–98. DOI:https://doi.org/10.5254/kv5ap920.